Skyrizi soars to top of Rx, OTC pharma brand rankings in July

Skyrizi was the top Rx and over-the-counter (OTC) pharma brand during July, according to data released by iSpot.tv on Monday afternoon.

Skyrizi recorded an impressions share of voice (SOV) of 5.18%, with 2.8 billion impressions last month. The AbbVie treatment for psoriasis, Crohn’s disease and psoriatic arthritis received most of its impressions SOV from NBC and its broadcasting of the 2024 Summer Olympics in Paris.